Skip to main content


Fig. 2 | Cancer Communications

Fig. 2

From: Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety

Fig. 2

Kaplan-Meier estimates illustrating the differences in a disease-free survival (DFS) and b overall survival (OS) of the enrolled patients who underwent radical hepatectomy alone against those who had radical hepatectomy and adjuvant TACE. TACE: transcatheter arterial chemoembolization; HR: hazard ratio; CI: confidence interval

Back to article page